跳至主要内容
临床试验/NCT02339597
NCT02339597Unknown不适用

Therapy Adherence in Different Settings of Automatic Positive Airway Pressure (APAP) Therapy Initiation in Patients With Obstructive Sleep Apnea (OSA): Comparison Between in Sleep-lab vs. at Home Environment.

Prof. Dr. Ingo Fietze2 个研究点 分布在 1 个国家目标入组 224 人开始时间: 2014年1月最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
224
试验地点
2
主要终点
Number of usage hours of of positive airway pressure therapy per night

研究概览

简要总结

Primary hypothesis:

The objective compliance ( # of hours per night of APAP therapy) is higher in patients who get the APAP treatment initiation at home due to the fact that they get better support by telemetric control and the possibility of prompt interventions.

Secondary hypothesis:

Based on the higher support at the home APAP initiation the following parameters will be better in comparison to the standard supply in laboratory:

Objective measures:

  • mask leakage
  • pressure
  • Apnea-Hypopnea-Index (AHI)

Subjective measures:

  • quality of life
  • sleepiness

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • written informed consent from patients after verbally and written informing
  • Age between 18 and 80 Years
  • obstructive sleep apnea syndrome (OSAS) with an AHI > 15/h and without previous therapy

排除标准

  • Intolerance to wear the PAP therapy mask
  • sleep breathing disorders (SBD) with central apneas > 20% and other sleep disorders
  • disabilities who prevents the wear of a therapy mask
  • initiated PAP therapy
  • pre-treatment of OSAS incl. UPPP (uvulo palato pharyngo plasty)
  • modified Mallampati Score T3 and T4
  • participation on clinical studies 4 weeks before start of the study
  • known or acute psychiatric/neurological or psychological disorders, who impairs the compliance to take part of the study.
  • chronical or new clinically significant pneumological or cardiovascular disease (exception: effectively therapies of hypertension, cardiac arrhythmia and coronal cardiac disease)
  • acute internistic disease
  • neuromuscular disease
  • condition after Apoplexy
  • oncological disease in recent 5 years
  • drug/alcohol consumption
  • consumption of von psychotropic drugs, hypnotics and other drugs who are able to influence the sleep/wake cycle

结局指标

主要结局

Number of usage hours of of positive airway pressure therapy per night

时间窗: 6 month

次要结局

  • Apnea Hypopnea Index [1 / hour of sleep)(6 month)

研究者

发起方
Prof. Dr. Ingo Fietze
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Prof. Dr. Ingo Fietze

Head of Sleep Lab

Charite University, Berlin, Germany

研究点 (2)

Loading locations...

相似试验